Europe Flowable Hemostats Market

The Europe flowable hemostats market is expected to grow from US$ 215.54 million in 2022 to US$ 328.23 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuel Europe Flowable Hemostats Market

The number of hospitals and surgical centers is increasing rapidly in developed and emerging regions. Such growth accelerates demand for surgical equipment (including medical devices and hemostat products) for lately established surgical centers and hospitals. In October 2020, the Prime Minister of the UK announced plans to invest around US$ 4.3 billion for the setting of 40 hospitals and a scheme for future funding for 48 hospitals by 2030. Furthermore, the growth in the healthcare sector offers lucrative opportunities for the flowable hemostats market. The healthcare industry has been encountering a rapid transformation in recent years. Various countries across the globe have favored advanced technologies in healthcare. With the need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being referred to in the healthcare systems, especially in emerging economies. Some of the primary factors, such as rising incidences of chronic illnesses, an increase in the aging population, and pediatric care, are helping boost the growth of the healthcare industry. With rising technical procedures, the effectiveness of topical hemostats may help improve clinical outcomes. Thus, the ideal topical hemostats would offer authentic and prompt bleeding control. Such significant growth in the number of hospitals and surgical centers demands high adoption of flowable hemostat products, ultimately offering lucrative growth opportunities for the market's growth during the coming years.

Europe Flowable Hemostats Market Overview

The Europe market for flowable hemostats is spread across Germany, the UK, France, Italy, Spain, and the Rest of Europe. This regional market is expected to witness a steady growth rate of 7.3% from 2022 to 2028 due to the rise in the number of surgical procedures, increasing government initiatives, growing healthcare expenditure, and several other factors. Germany has some specific medical facilities and trained physicians to treat patients worldwide. Besides, the country has the most advanced medical training facilities, and doctors are required to undergo extensive education, residency, and practice. As per the study obtained from the German Federal Statistical Office, the country had nearly 951,936 hospital staff and approximately 1,903 hospitals in 2020, which is expected to increase the number of surgeries in the country over the coming years. The growing number of surgical procedures is a crucial factor behind the rise in the hemostats market in Germany. For instance, according to the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), around 161,817 procedures were registered in 2019 across the country, out of which 92,809 were cardiac surgeries. Furthermore, Germany is the largest medical technology market and ranks third internationally. Approximately 11,000 medical devices are manufactured in the country, and two-thirds of its sales of medical devices were produced outside its domestic market. Germany is home to more than 30 dedicated cluster networks dedicated to innovative medical technology. The German Government's national high-tech strategy 2020 developed as a broad, interdepartmental advance strategy. Thus, factors, such as the growing number of hospitals and the rise in the number of surgeries, are likely to boost this market during the forecast period.

Europe Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Europe Flowable Hemostats Market Segmentation

The Europe flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the Europe flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the Europe flowable hemostats market in 2022.

In terms of product, the Europe flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the Europe flowable hemostats market in 2022.

Based on application, the Europe flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the Europe flowable hemostats market in 2022.

Based on end user, the Europe flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the Europe flowable hemostats market in 2022.

By country, the Europe flowable hemostats market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the Europe flowable hemostats market.

Europe Flowable Hemostats Strategic Insights

Strategic insights for the Europe Flowable Hemostats provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Flowable Hemostats Report Scope

Europe Flowable Hemostats Regional Insights

The geographic scope of the Europe Flowable Hemostats refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.